Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

NCT00005851

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • Baylor University Medical Center Dallas, Texas, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Completed

Clinical Study of WT2725 in Patients With Advanced Malignancies

NCT01621542

Conditions
Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +20 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

NCT01415167

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Southern California Permanente Medical Group Riverside, California, United States
View all 45 locations
View Trial Details

Related conditions